-
公开(公告)号:ZA8905176B
公开(公告)日:1990-03-28
申请号:ZA8905176
申请日:1989-07-07
Applicant: HOECHST AG
Inventor: KLOSA JOSEF , JOSEF KLOSA , KROEGER HANS , HANS KROEGER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHRINNER ELMAR , ELMAR SCHRINNER
IPC: A61K31/52 , A61P31/12 , C07D473/38 , C07D
CPC classification number: C07D473/38
-
公开(公告)号:PT90660A
公开(公告)日:1989-11-30
申请号:PT9066089
申请日:1989-05-24
Applicant: HOECHST AG
Inventor: HAENEL HEINZ , SCHRINNER ELMAR
IPC: C07D473/10 , A61K31/35 , A61K31/52 , A61K31/522 , A61K39/395 , A61K45/06 , A61P35/00
Abstract: Medicines which contain a substance which liberates tumour necrosis factor (TNF) are better tolerated and can be given in higher doses when they contain a TNF inhibitor, especially a xanthine derivative.
-
公开(公告)号:DK258989D0
公开(公告)日:1989-05-26
申请号:DK258989
申请日:1989-05-26
Applicant: HOECHST AG
Inventor: HAENEL HEINZ , SCHRINNER ELMAR
IPC: C07D473/10 , A61K31/35 , A61K31/52 , A61K31/522 , A61K39/395 , A61K45/06 , A61P35/00 , A61K31/72
Abstract: Medicines which contain a substance which liberates tumour necrosis factor (TNF) are better tolerated and can be given in higher doses when they contain a TNF inhibitor, especially a xanthine derivative.
-
公开(公告)号:ZA8805577B
公开(公告)日:1989-04-26
申请号:ZA8805577
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , ELMAR SCHRINNER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K , C07D , C08B
CPC classification number: A61K31/715 , A61K31/52
-
公开(公告)号:HUT44926A
公开(公告)日:1988-05-30
申请号:HU252587
申请日:1987-06-02
Applicant: HOECHST AG
Inventor: LIMBERT MICHAEL , SCHRINNER ELMAR , SEIBERT GERHARD
IPC: A61K31/545 , A61P31/04 , A61K31/43
Abstract: Pharmaceutical preparation having a synergistic, antibacterial activity and containing a) a cephalosporin derivative or physiologically acceptable salts or esters thereof, and b) a penem antibiotic of the basic structure (B) or physiologically acceptable salts or esters thereof, process for manufacturing such a preparation, and its use in the treatment of bacterial infections.
-
公开(公告)号:DK409687A
公开(公告)日:1988-02-08
申请号:DK409687
申请日:1987-08-06
Applicant: HOECHST AG
Inventor: SEIBERT GERHARD , SCHRINNER ELMAR
-
公开(公告)号:AU7379587A
公开(公告)日:1987-12-10
申请号:AU7379587
申请日:1987-06-03
Applicant: HOECHST AG
Inventor: LIMBERT MICHAEL , SCHRINNER ELMAR , SEIBERT GERHARD
IPC: A61K31/545 , A61P31/04 , A61K31/54
Abstract: Pharmaceutical preparation having a synergistic, antibacterial activity and containing a) a cephalosporin derivative or physiologically acceptable salts or esters thereof, and b) a penem antibiotic of the basic structure (B) or physiologically acceptable salts or esters thereof, process for manufacturing such a preparation, and its use in the treatment of bacterial infections.
-
公开(公告)号:NO872331L
公开(公告)日:1987-12-07
申请号:NO872331
申请日:1987-06-03
Applicant: HOECHST AG
Inventor: LIMBERT MICHAEL , SCHRINNER ELMAR , SEIBERT GERHARD
IPC: A61K31/545 , A61P31/04 , A61K
Abstract: Pharmaceutical preparation having a synergistic, antibacterial activity and containing a) a cephalosporin derivative or physiologically acceptable salts or esters thereof, and b) a penem antibiotic of the basic structure (B) or physiologically acceptable salts or esters thereof, process for manufacturing such a preparation, and its use in the treatment of bacterial infections.
-
公开(公告)号:DK409687D0
公开(公告)日:1987-08-06
申请号:DK409687
申请日:1987-08-06
Applicant: HOECHST AG
Inventor: SEIBERT GERHARD , SCHRINNER ELMAR
-
公开(公告)号:FI872459A0
公开(公告)日:1987-06-02
申请号:FI872459
申请日:1987-06-02
Applicant: HOECHST AG
Inventor: LIMBERT MICHAEL , SCHRINNER ELMAR , SEIBERT GERHARD
IPC: A61K31/545 , A61P31/04 , A61K
Abstract: Pharmaceutical preparation having a synergistic, antibacterial activity and containing a) a cephalosporin derivative or physiologically acceptable salts or esters thereof, and b) a penem antibiotic of the basic structure (B) or physiologically acceptable salts or esters thereof, process for manufacturing such a preparation, and its use in the treatment of bacterial infections.
-
-
-
-
-
-
-
-
-